ArticleESMO real world data and digital oncology2025

Definitions, measurement, and reporting of progression-free survival in randomized clinical trials and observational studies of patients with advanced non-small-cell lung cancer treated with immunotherapy: a scoping review.

M V Verschueren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.